| 1 |
Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis |
|
|
| Nitin Verma, Vimal Arora, Rajendra Awasthi, Yinghan Chan, Niraj Kumar Jha, Komal Thapa, Talha Jawaid, Mehnaz Kamal, Gaurav Gupta, Gang Liu, Keshav Raj Paudel, Philip Michael Hansbro, Brian Gregory George Oliver, Sachin Kumar Singh, Dinesh Kumar Chellappan, Harish Dureja, Kamal Dua |
|
| Journal of Drug Delivery Science and Technology. 2022; : 103690 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives |
|
|
| Minhua Chen, Zhangxuan Shou, Xue Jin, Yingjun Chen |
|
| Drug Delivery. 2022; 29(1): 2442 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
The respiratory lipoquinone, menaquinone, functions as an inducer of genes regulated by the Mycobacterium smegmatis repressor MSMEG_2295 |
|
|
| Anik Barman, Madhu Manti Patra, Sujoy K. Das Gupta |
|
|
Microbiology
. 2022; 168(5) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Nontuberculous Mycobacterial Resistance to Antibiotics and Disinfectants: Challenges Still Ahead |
|
|
| Samira Tarashi, Seyed Davar Siadat, Abolfazl Fateh, Fu-Ming Tsai |
|
| BioMed Research International. 2022; 2022: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Discovery and Development of Antibacterial Agents: Fortuitous and
Designed |
|
|
| Ravleen Kaur, Pooja Rani, Atanas G. Atanasov, Qushmua Alzahrani, Reena Gupta, Bhupinder Kapoor, Monica Gulati, Pooja Chawla |
|
| Mini-Reviews in Medicinal Chemistry. 2022; 22(7): 984 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Hit Compounds and Associated Targets in Intracellular Mycobacterium tuberculosis |
|
|
| Clement K. M. Tsui, Flavia Sorrentino, Gagandeep Narula, Alfonso Mendoza-Losana, Ruben Gonzalez del Rio, Esther Pérez Herrán, Abraham Lopez, Adama Bojang, Xingji Zheng, Modesto Jesus Remuiñán-Blanco, Yossef Av-Gay |
|
| Molecules. 2022; 27(14): 4446 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
AN INSIGHT INTO PRIVILEGED SCAFFOLDS IN TUBERCULOSIS: DEVELOPMENTAL ASPECTS AND IMPLICATIONS IN DRUG DESIGN |
|
|
| Rani. A. Shinde, Vasanti. M. Suvarna, Arundhati. N. Abhyankar |
|
| Indian Drugs. 2022; 59(01): 7 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Impact of drug-resistant tuberculosis treatment on hearing function in South African adults: Bedaquiline versus kanamycin |
|
|
| Katijah Khoza-Shangase, Marina Prodromos |
|
| South African Journal of Communication Disorders. 2021; 68(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018) |
|
|
| Mahanjit Konwar, MiteshR Maurya, TusharB Nishandar, UrmilaM Thatte, NithyaJ Gogtay |
|
| Perspectives in Clinical Research. 2021; 12(3): 159 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
A review of current and promising nontuberculous mycobacteria antibiotics |
|
|
| Christophe R Cantelli, Alexandra Dassonville-Klimpt, Pascal Sonnet |
|
| Future Medicinal Chemistry. 2021; 13(16): 1367 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era |
|
|
| Alina Minias, Lidia Zukowska, Ewelina Lechowicz, Filip Gasior, Agnieszka Knast, Sabina Podlewska, Daria Zygala, Jaroslaw Dziadek |
|
| Frontiers in Microbiology. 2021; 11 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Knowledge Gaps in the Understanding of Antimicrobial Resistance in Canada |
|
|
| Kayley D. McCubbin, R. Michele Anholt, Ellen de Jong, Jennifer A. Ida, Diego B. Nóbrega, John P. Kastelic, John M. Conly, Matthias Götte, Tim A. McAllister, Karin Orsel, Ian Lewis, Leland Jackson, Graham Plastow, Hans-Joachim Wieden, Kathy McCoy, Myles Leslie, Joan L. Robinson, Lorian Hardcastle, Aidan Hollis, Nicholas J. Ashbolt, Sylvia Checkley, Gregory J. Tyrrell, André G. Buret, Elissa Rennert-May, Ellen Goddard, Simon J. G. Otto, Herman W. Barkema |
|
| Frontiers in Public Health. 2021; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics |
|
|
| Bismillah Mubeen, Aunza Nayab Ansar, Rabia Rasool, Inam Ullah, Syed Sarim Imam, Sultan Alshehri, Mohammed M. Ghoneim, Sami I. Alzarea, Muhammad Shahid Nadeem, Imran Kazmi |
|
| Antibiotics. 2021; 10(12): 1473 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
A Test System for in vitro Screening Antimycobacterial Drug Candidates for MmpS5-MmpL5 Mediated Resistance |
|
|
| K. V. Shur, S. G. Frolova, N. I. Akimova, V. N. Danilenko, D. A. Maslov |
|
| Russian Journal of Genetics. 2021; 57(1): 114 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
The antimicrobial and immunomodulatory effects of Ionophores for the treatment of human infection |
|
|
| Gen Li, David M.P. De Oliveira, Mark J. Walker |
|
| Journal of Inorganic Biochemistry. 2021; : 111661 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance |
|
|
| Mark Laws, Peiqin Jin, Khondaker Miraz Rahman |
|
| Trends in Microbiology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Applicability of Chromatographic Co-Elution for Antibiotic Target Identification |
|
|
| Sina Schäkermann, Dominik Wüllner, Abdulkadir Yayci, Andrew Emili, Julia Elisabeth Bandow |
|
| PROTEOMICS. 2021; 21(1): 2000038 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Safety, efficacy, and serum concentration monitoring of bedaquiline in Chinese patients with multidrug-resistant tuberculosis |
|
|
| Jinmeng Li, Gaoyi Yang, Qingshan Cai, Yu Wang, Yingying Xu, Ruoying Zhang, Yazhen Lang, Xinjun Cai |
|
| International Journal of Infectious Diseases. 2021; 110: 179 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives |
|
|
| Elliasu Y. Salifu, Clement Agoni, Fisayo A. Olotu, Mahmoud E.S. Soliman |
|
| Computational Biology and Chemistry. 2020; 85: 107204 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Inhibition of Mycobacterium tuberculosis InhA: Design, synthesis and evaluation of new di-triclosan derivatives |
|
|
| Tom Armstrong, Malcolm Lamont, Alice Lanne, Luke J. Alderwick, Neil R. Thomas |
|
| Bioorganic & Medicinal Chemistry. 2020; 28(22): 115744 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Multitarget Approaches against Multiresistant Superbugs |
|
|
| Declan Alan Gray, Michaela Wenzel |
|
| ACS Infectious Diseases. 2020; 6(6): 1346 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids |
|
|
| Alka Pawar, Prakash Jha, Madhu Chopra, Uma Chaudhry, Daman Saluja |
|
| Scientific Reports. 2020; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Two Decades of TB Drug Discovery Efforts—What Have We Learned? |
|
|
| Balachandra Bandodkar, Radha Krishan Shandil, Jagadeesh Bhat, Tanjore S. Balganesh |
|
| Applied Sciences. 2020; 10(16): 5704 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Bedaquiline: A Mini Review
|
|
|
| Nandhini Saravanabavan, Padmavathi Shanmuganathan, Manimekalai Kumarappan |
|
| Annals of SBV. 2020; 8(1): 2 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Mycobacterial tryptophan biosynthesis: A promising target for tuberculosis drug development? |
|
|
| Sara Consalvi, Cristina Scarpecci, Mariangela Biava, Giovanna Poce |
|
| Bioorganic & Medicinal Chemistry Letters. 2019; 29(23): 126731 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
The Emergence of Phenolic Glycans as Virulence Factors in Mycobacterium tuberculosis |
|
|
| Danielle D. Barnes, Mimmi L. E. Lundahl, Ed C. Lavelle, Eoin M. Scanlan |
|
| ACS Chemical Biology. 2017; 12(8): 1969 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
